Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain
Officers.
Compensation Arrangement of Certain Officers
On November 4, 2009, the Compensation Committee of the Board of Directors of
Gilead Sciences, Inc. (the Company) approved the target bonus levels to be in
effect under the Company's Corporate Bonus Plan for the 2010 fiscal year for the
Company's current named executive officers (the Executive Officers). The target
bonus levels for the 2009 and 2010 fiscal years are summarized below:
Executive Officer 2009 Target Bonus 2010 Target Bonus
(as a % of Base Salary) (as a % of Base Salary)
John C. Martin 125 % 130 %
Chairman and Chief Executive
Officer
John F. Milligan 75 % 90 %
President and Chief Operating
Officer
Norbert W. Bischofberger 60 % 70 %
Executive Vice President,
Research and Development and
Chief Scientific Officer
Kevin Young 60 % 70 %
Executive Vice President,
Commercial Operations
Gregg H. Alton 60 %* 70 %
Executive Vice President,
Corporate and Medical Affairs
Robin L. Washington 55 % 60 %
Senior Vice President and
Chief Financial Officer
|
* In July 2009, in connection with Mr. Alton's appointment to serve as the
Company's Executive Vice President, Corporate and Medical Affairs, the 2009
target bonus payable to him was increased from 55% of base salary to 60% of
base salary. The amount of his 2009 target bonus will be prorated to reflect
when he was promoted and moved to the higher target bonus.
The Company's Board of Directors ratified the target bonus level of Dr. Martin.
No other terms have yet been established under the 2010 Corporate Bonus Plan for
the Executive Officers.
